PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

37,358 stories, page 183 of 623

Advanced search
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: MELAO Hydrating Lightweight Sunscreen

Official structured record identifier: 59eeaea1-d726-99f3-e063-6394a90aeea3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Jardiance

Official structured record identifier: 59ed43d9-b4e0-72a2-e063-6394a90a327d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: METOPROLOL TARTRATE

Official structured record identifier: 59ed1885-cc00-5325-e063-6294a90a50c2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Metoprolol succinate

Official structured record identifier: 59ed0d9a-54c8-4c13-e063-6394a90a2aaa.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ticagrelor

Official structured record identifier: 555d4e44-9bb2-474e-9bea-c549e3261dbb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Trazodone Hydrochloride

Official structured record identifier: 3b2e61b0-414c-48ae-9e13-06470c302c67.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: OXYGEN

Official structured record identifier: 36b3f07a-d7f9-4d52-b40a-73d65e4f83ba.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: CETIRIZINE HYDROCHLORIDE

Official structured record identifier: 36b24a3c-6284-5a6d-e063-6394a90a7743.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Zicam Cold Remedy RapidMelts Original and Nighttime Convenience Pack

Official structured record identifier: 364ddb15-ab08-6270-e063-6394a90ab935.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: cholestyramine powder for suspension

Official structured record identifier: 31d04422-f159-42ba-8eb5-b0ec1dbc52f9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Calcium Chloride

Official structured record identifier: 3089499b-142d-482e-889d-1db4da7b1152.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Doxycycline

Official structured record identifier: 2c29f716-bdb0-437d-92a4-d856b87db976.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Chlorpromazine hydrochloride

Official structured record identifier: 2bd42d3a-bf89-4d74-a252-9b914106a570.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Leader Dual Action Pain Reliever

Official structured record identifier: 2bb1f616-48af-4fe1-9aa9-32fcb2dba50c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ibuprofen

Official structured record identifier: 2572ed69-d5a7-4513-a202-aca3230e7ec5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: prednisone

Official structured record identifier: 23b12d22-97d6-426e-bf9c-dd6c2ff77370.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Desloratadine

Official structured record identifier: 21174c0f-9204-4c75-b6e6-2f9ada5b535d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 1b0919aa-0d41-4c91-9ef4-049ac9e27d78.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Gabapentin

Official structured record identifier: 1af098ad-28b5-463f-8efa-24d70a77d64c.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Ciprofloxacin Hydrochloride

Official structured record identifier: 14c3bc33-201d-492e-9aee-a4d84c813a3d.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Hero Force Shield Superlight Sunscreen SPF 30

Official structured record identifier: 140268a9-adb9-4574-ad82-4a2e924dc808.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SPIRONOLACTONE

Official structured record identifier: 122558a0-57bb-4195-9adf-d37b049cbfb5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Icosapent Ethyl

Official structured record identifier: 0ee78f22-bed2-48f8-9be8-b8f6ceeeaeaf.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Benzonatate

Official structured record identifier: 07018b47-76f5-49d3-b7d3-081f82d382b2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: anti diarrheal and anti gas

Official structured record identifier: 065699b5-217e-432f-a253-cea2d3f62233.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lidocaine Pain Relief Patch 5 Ct

Official structured record identifier: 025d508b-ec4f-466c-b3e8-ba9b18d07b46.

openFDA Drug LabelsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Merck Drug Price Row Loss, $56M Biotech Verdict And More

Law360Original source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Peripheral Nerve Blocks Modulate the Pain-Mood Relationship in Bariatric Surgery: A Secondary Analysis of a Randomized, Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Current and future therapies for triple-negative breast cancer.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Study protocol for a phase II clinical trial evaluating the safety and efficacy of favipiravir injection combined with oseltamivir in influenza treatment.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Implantable medical devices: From basics to state-of-the-art.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Decreased accumbens-amygdala connectivity is associated with sleep improvement in late-life depression following mindfulness-based cognitive therapy.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A phase I clinical study of the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-2106, an anti-CD40 antibody, following single intravenous or subcutaneous administration in healthy participants.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Comment on "The effect of pretreatment of the pilosebaceous unit on Cutibacterium acnes burden during shoulder arthroplasty: a randomized controlled trial".

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Enhancing Hepatitis B case finding through tech-enhanced community pharmacy: Results from a trial program in Vietnam.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Amino acid homeostasis by CORVET/HOPS: A metabolic and stress resilience checkpoint for T cells.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Why Serum Magnesium Fails: A Narrative Review of Magnesium Biochemistry, Compartmental Exchange, and Endpoint Selection for Supplementation Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Next-Generation Pharmacotherapies for Unipolar Mood Disorders: A Leading Article on Phase II/III Drug Development Across Diverse Mechanisms.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Effect of herbal formula based on rosa damascena on functional bloating severity in older adults: a pilot double-blind randomized controlled trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Real-world safety and effectiveness of nivolumab in patients with cancer of unknown primary: results from a nationwide post-marketing surveillance in Japan.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Factors Affecting Acceptance of Participating in Clinical Trials of New Drugs: A National Cross-Sectional Study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Aerobic exercise attenuates peri-infarct fibrosis and improves fitness early after acute myocardial infarction: a randomized trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Bruton's tyrosine kinase inhibition for food-induced anaphylaxis.

Europe PMCOriginal source
🌍Researchdoi.orgTier 1 · Research record

Association Between Cervical Lordosis Restoration and Clinical Recovery Following a Motor Vehicle Collision: A Chiropractic BioPhysics Case Report With a 17-Month Follow-Up

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Network-based drug response prediction, with multi-omics data: DrDimont and beyond

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Glycemic Control and Cognitive Function in Dysglycemia: A Mediation Analysis of Depressive Symptoms Using NHANES 2011–2014

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

ADHD Medication Safety in Pregnancy

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Theoretical, psychological, and regulatory dimensions of modern pharmaceutical marketing: implications for patient behavior and healthcare systems

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Structured educational program for healthcare professionals improves outcomes of atrial fibrillation management: A Polish subgroup analysis of the European Society of Cardiology STEEER-AF cluster-randomized trial

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Development and Preclinical Evaluation of a Dual-Drug Implant for Long-Acting HIV Prevention and Contraception

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Serum Trefoil Factor 3 in Endometrioid Endometrial Carcinoma: Exploratory Diagnostic Value and Association with Lymphovascular Space Invasion

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Myocardial Bridging in Sports and Exercise Cardiology: Screening Challenges, Clinical Management, and Physical Activity Guidance

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Outcomes of Physician-Modified Endografts for Juxtarenal and Pararenal Abdominal Aortic Aneurysms: A Systematic Review and Single-Arm Meta-Analysis

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Cardiac Rehabilitation in Heart Failure: Evidence, Coverage, and Implementation

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Added Value of One-Month Clinical Data in Predicting Chronic-Stage Motor Function After Ischemic Stroke

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Real-World Assessment of Direct Oral Factor Xa Inhibitors: Dosing Appropriateness, Drug Exposure, and Inter-Platform Comparability of Chromogenic Anti-Xa Assays

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Potential Therapeutic Roles of Icariin in Inflammatory Diseases: From Molecular Mechanisms to Clinical Translation Prospects

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Recognising and responding to clinical deterioration in acute hospitals. Recording patient-reported wellness after Martha's rule

CrossrefOriginal source
🌍Researchdoi.orgTier 1 · Research record

Transition from drug lag to drug loss in pediatric oncology: a comprehensive evaluation of the Japan-U.S. approval gap

CrossrefOriginal source